{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:46:32Z","timestamp":1784544392802,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T00:00:00Z","timestamp":1304294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00210-011-0627-9","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T14:52:57Z","timestamp":1304261577000},"page":"647-654","source":"Crossref","is-referenced-by-count":13,"title":["Inhibition of 1,4-butanediol metabolism in human liver in vitro"],"prefix":"10.1007","volume":"383","author":[{"given":"Daniel","family":"Lenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"J\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Wintermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Beike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"K\u00e4ferstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,2]]},"reference":[{"issue":"8","key":"627_CR1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0006-2952(72)90107-4","volume":"21","author":"SP Bessman","year":"1972","unstructured":"Bessman SP, McCabe RB (1972) 1,4-butanediol\u2014substrate for rat-liver and horse liver alcohol dehydrogenases. Biochem Pharmacol 21(8):1135\u20131142","journal-title":"Biochem Pharmacol"},{"issue":"21","key":"627_CR2","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1056\/NEJMct0806112","volume":"360","author":"J Brent","year":"2009","unstructured":"Brent J (2009) Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med 360(21):2216\u20132223","journal-title":"N Engl J Med"},{"issue":"3","key":"627_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(02)01502-9","volume":"441","author":"MAM Carai","year":"2002","unstructured":"Carai MAM, Colombo G, Reali R, Serra S, Mocci I, Castelli MP, Cignarella G, Gessa GL (2002) Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid. Eur J Pharmacol 441(3):157\u2013163","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"627_CR4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.annemergmed.2005.10.011","volume":"47","author":"MAM Carai","year":"2006","unstructured":"Carai MAM, Colombo G, Quang LS, Maher TJ, Gessa GL (2006) Resuscitative treatments on 1,4-butanediol mortality in mice. Ann Emerg Med 47(2):184\u2013189. doi: 10.1016\/j.annemergmed.2005.10.011","journal-title":"Ann Emerg Med"},{"key":"627_CR5","first-page":"102","volume":"14","author":"FJ Couper","year":"2002","unstructured":"Couper FJ, Marinetti LJ (2002) Hydroxybutyrate(GHB)\u2014effects on human performance and behavior. Forensic Sci Rev 14:102\u2013121","journal-title":"Forensic Sci Rev"},{"issue":"9","key":"627_CR6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s002040050550","volume":"72","author":"K Dawidek-Pietryka","year":"1998","unstructured":"Dawidek-Pietryka K, Szczepaniak S, Dudka J, Mazur M (1998) In vitro studies of human alcohol dehydrogenase inhibition in the process of methanol and ethylene glycol oxidation. Arch Toxicol 72(9):604\u2013607","journal-title":"Arch Toxicol"},{"issue":"7","key":"627_CR7","first-page":"113","volume":"47","author":"DA Dempsey","year":"2009","unstructured":"Dempsey DA, Wiegand TJ, Havel C, Benowitz NL, Haller C (2009) Butanediol (BD) conversion to gamma-hydroxybutyrate, (GHB), is markedly reduced by fomepizole (4-MP), an alcohol dehydrogenase blocker. Clin Toxicol 47(7):113","journal-title":"Clin Toxicol"},{"issue":"7","key":"627_CR8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jat\/25.7.576","volume":"25","author":"WC Duer","year":"2001","unstructured":"Duer WC, Byers KL, Martin JV (2001) Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol. J Anal Toxicol 25(7):576\u2013582","journal-title":"J Anal Toxicol"},{"key":"627_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0091-3057(83)90162-4","volume":"18","author":"CJP Eriksson","year":"1983","unstructured":"Eriksson CJP (1983) Human-blood acetaldehyde concentration during ethanol oxidation (update 1982). Pharmacol Biochem Behav 18:141\u2013150","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"627_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1208\/s12248-007-9006-3","volume":"10","author":"HL Fung","year":"2008","unstructured":"Fung HL, Tsou PS, Bulitta JB, Tran DC, Page NA, Soda D, Fung SM (2008) Pharmacokinetics of 1,4-butanediol in rats: bioactivation to gamma-hydroxybutyric acid, interaction with ethanol, and oral bioavailability. AAPS J 10(1):56\u201369. doi: 10.1208\/s12248-007-9006-3","journal-title":"AAPS J"},{"issue":"6","key":"627_CR11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jat\/29.6.582","volume":"29","author":"P Kintz","year":"2005","unstructured":"Kintz P, Villain M, Pelissier AL, Cirimele V, Leonetti G (2005) Unusually high concentrations in a fatal GHB case. J Anal Toxicol 29(6):582\u2013585","journal-title":"J Anal Toxicol"},{"issue":"2","key":"627_CR12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0003-2697(83)90095-7","volume":"133","author":"PJ Lad","year":"1983","unstructured":"Lad PJ, Leffert HL (1983) rat-liver alcohol-dehydrogenase.1. purification and characterization. Anal Biochem 133(2):350\u2013361","journal-title":"Anal Biochem"},{"issue":"6","key":"627_CR13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/FTD.0b013e3181898c2e","volume":"30","author":"D Lenz","year":"2008","unstructured":"Lenz D, Rothschild MA, Kroner L (2008) Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone. Ther Drug Monit 30(6):755\u2013761","journal-title":"Ther Drug Monit"},{"issue":"3","key":"627_CR14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0379-0738(02)00424-3","volume":"133","author":"C Lora-Tamayo","year":"2003","unstructured":"Lora-Tamayo C, Tena T, Rodriguez A, Sancho JR, Molina E (2003) Intoxication due to 1,4-butanediol. Forensic SciInt 133(3):256\u2013259","journal-title":"Forensic SciInt"},{"issue":"1","key":"627_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/CLT-120002888","volume":"40","author":"B Megarbane","year":"2002","unstructured":"Megarbane B, Fompeydie D, Garnier R, Baud FJ (2002) Treatment of a 1,4-butanediol poisoning with fomepizole. J Toxicol Clin Toxicol 40(1):77\u201380","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"627_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0028-3908(84)90226-0","volume":"23","author":"F Poldrugo","year":"1984","unstructured":"Poldrugo F, Snead OC (1984) 1,4 butanediol, gamma-hydroxybutyric acid and ethanol\u2014relationships and interactions. Neuropharmacology 23(1):109\u2013113","journal-title":"Neuropharmacology"},{"issue":"6","key":"627_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0741-8329(86)90055-8","volume":"3","author":"F Poldrugo","year":"1986","unstructured":"Poldrugo F, Snead OC (1986) 1,4 butanediol and ethanol compete for degradation in rat-brain and liver invitro. Alcohol 3(6):367\u2013370","journal-title":"Alcohol"},{"issue":"6","key":"627_CR18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1530-0277.1985.tb05589.x","volume":"9","author":"F Poldrugo","year":"1985","unstructured":"Poldrugo F, Barker S, Basa M, Mallardi F, Snead OC (1985) Ethanol potentiates the toxic effects of 1,4-butanediol. Alcoholism 9(6):493\u2013497","journal-title":"Alcoholism"},{"key":"627_CR19","doi-asserted-by":"crossref","unstructured":"Quang LS, DeSai MC, Shannon MW, Woolf AD, Maher TJ (2004) 4-methylpyrazole decreases 1,4-butanediol toxicity by blocking its in vivo biotransformation to gamma-hydroxybutyric acid. In: Ali SF, Nabeshima T, Yanagita T (eds) Current status of drug dependence\/abuse studies: cellular and molecular mechanisms of drugs of abuse and neurotoxicity, vol 1025. Annals of the New York Academy of Sciences. New York Acad Sciences, New York, pp 528\u2013537. doi: 10.1196\/annals.1316.065","DOI":"10.1196\/annals.1316.065"},{"issue":"4","key":"627_CR20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3891\/acta.chem.scand.23-1119","volume":"23","author":"M Reynier","year":"1969","unstructured":"Reynier M (1969) Pyrazole inhibition and kinetic studies of ethanol and retinol oxidation catalyzed by rat liver alcohol dehydrogenase. Acta Chem Scand 23(4):1119\u20131129","journal-title":"Acta Chem Scand"},{"issue":"7","key":"627_CR21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0006-2952(00)00435-4","volume":"60","author":"ML Shen","year":"2000","unstructured":"Shen ML, Lipsky JJ, Naylor S (2000) Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase. Biochem Pharmacol 60(7):947\u2013953","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"627_CR22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76\u201385","journal-title":"Anal Biochem"},{"issue":"26","key":"627_CR23","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1056\/NEJMra044047","volume":"352","author":"OC Snead","year":"2005","unstructured":"Snead OC, Gibson KM (2005) Drug therapy\u2014gamma-hydroxybutyric acid. N Engl J Med 352(26):2721\u20132732","journal-title":"N Engl J Med"},{"issue":"1","key":"627_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3891\/acta.chem.scand.23-0255","volume":"23","author":"H Theorell","year":"1969","unstructured":"Theorell H, Yonetani T (1969) On effects of some heterocyclic compounds on enzymic activity of liver alcohol dehydrogenase. Acta Chem Scand 23(1):255\u2013260","journal-title":"Acta Chem Scand"},{"issue":"2","key":"627_CR25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/oxfordjournals.alcalc.a044872","volume":"24","author":"S Tsukamoto","year":"1989","unstructured":"Tsukamoto S, Muto T, Nagoya T, Shimamura M, Saito M, Tainaka H (1989) Determinations of ethanol, acetaldehyde and acetate in blood and urine during alcohol oxidation in man. Alcohol Alcohol 24(2):101\u2013108","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"627_CR26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1530-0277.1989.tb00372.x","volume":"13","author":"A Zorzano","year":"1989","unstructured":"Zorzano A, Herrera E (1989) Decreased in vivo rate of ethanol-metabolism in the suckling rat. Alcoholism 13(4):527\u2013532","journal-title":"Alcoholism"},{"issue":"2","key":"627_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM200101113440202","volume":"344","author":"DL Zvosec","year":"2001","unstructured":"Zvosec DL, Smith SW, McCutcheon JR, Spillane J, Hall BJ, Peacock EA (2001) Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med 344(2):87\u201394","journal-title":"N Engl J Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0627-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-011-0627-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0627-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T12:11:30Z","timestamp":1560168690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-011-0627-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,2]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1007\/s00210-011-0627-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,2]]}}}